SCHEMBL4601007

SCHEMBL4601007

Cc1ccccc1CCC(=O)Cl

nearest known ligand 0.50

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ TAAR1 Q96RJ0 1/20 0.50
▸ NOTUM Q6P988 1/20 0.48
▸ ALDH1A1 P00352 2/20 0.46
▸ HPGD P15428 2/20 0.43
▸ CTBP2 P56545 1/20 0.43
▸ THRA P10827 1/20 0.42
▸ THRB P10828 1/20 0.42
▸ CYP4F2 P78329 1/20 0.42
▸ CYP4A11 Q02928 1/20 0.42
▸ GPR84 Q9NQS5 1/20 0.41
▸ DAO P14920 2/20 0.41
▸ NPC1 O15118 1/20 0.41
▸ RAB9A P51151 1/20 0.41
▸ HTT P42858 1/20 0.40
▸ HSP90AA1 P07900 1/20 0.40
▸ GAA P10253 1/20 0.40
▸ KMT2A Q03164 1/20 0.40
▸ MAOB P27338 1/20 0.40
▸ NPSR1 Q6W5P4 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29053313 0.89 TAAR1 (0.47) TAAR1NOTUMALDH1A1HPGDCTBP2
SCHEMBL7331759 0.83 TAAR1 (0.54) TAAR1NOTUMALDH1A1HPGDCTBP2
SCHEMBL19519963 0.82 IAPP (0.38) NOTUMALDH1A1HPGDCYP4F2CYP4A11
SCHEMBL29843018 0.82 IAPP (0.56) TAAR1NOTUMALDH1A1HPGDCTBP2
SCHEMBL323867 0.82 NPSR1 (0.61) TAAR1NOTUMALDH1A1HPGDCTBP2
SCHEMBL6959430 0.82 TAAR1 (0.52) TAAR1NOTUMALDH1A1HPGDCTBP2
SCHEMBL1404957 0.82 IAPP (0.56) TAAR1NOTUMALDH1A1HPGDCTBP2
SCHEMBL4601863 0.82 CYP4F2 (0.47) ALDH1A1CYP4F2CYP4A11GAA
SCHEMBL29843936 0.82 NPSR1 (0.61) TAAR1NOTUMALDH1A1HPGDCTBP2
Water SCHEMBL10936872 0.80 NPSR1 (0.59) TAAR1NOTUMALDH1A1HPGDCTBP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 53 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240417379-A1 P2X4 RECEPTOR ANTAGONIST NIPPON CHEMIPHAR CO., LTD (JP) 2024-12-19 — — US disclosed
US-12116351-B2 P2X4 receptor antagonist NIPPON CHEMIPHAR CO., LTD (JP) 2024-10-15 — — US disclosed
US-20220380322-A1 P2X4 RECEPTOR ANTAGONIST NIPPON CHEMIPHAR CO., LTD (JP) 2022-12-01 — — US disclosed
US-11434207-B2 P2X4 receptor antagonist NIPPON CHEMIPHAR CO., LTD (JP) 2022-09-06 — — US disclosed
CN-108863959-B P2X4 receptor antagonists 日本化学药品株式会社 2021-11-30 — — CN disclosed
US-20200223806-A1 P2X4 RECEPTOR ANTAGONIST NIPPON CHEMIPHAR CO., LTD (JP) 2020-07-16 — — US disclosed
CN-111333588-A P2X4 receptor antagonists 日本化学药品株式会社 2020-06-26 — — CN disclosed
US-10633349-B2 P2X4 receptor antagonist NIPPON CHEMIPHAR CO., LTD (JP) 2020-04-28 — — US disclosed
CN-104066724-B P2X4 receptor antagonists 日本化学药品株式会社 2020-04-17 — — CN disclosed
CN-105431510-B Organic compounds 奇华顿股份有限公司 2020-02-11 — — CN disclosed
EP-1243582-A1 QUINOLINE AND QUINAZOLINE DERIVATIVES AND DRUGS CONTAINING THE SAME KIRIN BEER KABUSHIKI KAISHA (JP) 2002-09-25 — — EP disclosed
CN-1370047-A Fungicidal agents AVENTIS CROPSCIENCE GMBH (DE) 2002-09-18 — — CN disclosed
EP-1204643-A2 FUNGICIDAL HETEROCYCLIC AROMATIC AMIDES AND THEIR COMPOSITIONS, METHODS OF USE AND PREPARATION Dow AgroSciences LLC (US) 2002-05-15 — — EP disclosed
EP-1196388-A2 FUNGICIDAL HETEROCYCLIC AROMATIC AMIDES AND THEIR COMPOSITIONS, METHODS OF USE AND PREPARATION Dow AgroSciences LLC (US) 2002-04-17 — — EP disclosed
WO-2002018437-A2 CYCLIC PEPTIDES HAVING MELANOCORTIN-4 RECEPTOR AGONIST ACTIVITY F. HOFFMANN-LA ROCHE AG (CH) 2002-03-07 — — WO disclosed
US-20010056179-A1 Selective linear peptides with melanocortin-4 receptor (MC4-R) agonist activity HOFFMANN-LA ROCHE INC. 2001-12-27 — — US disclosed
WO-2001074844-A2 SELECTIVE LINEAR PEPTIDES WITH MELANOCORTIN-4 RECEPTOR (MC4-R) AGONIST ACTIVITY F. HOFFMANN-LA ROCHE AG (CH) 2001-10-11 — — WO disclosed
WO-2001014339-A2 FUNGICIDAL HETEROCYCLIC AROMATIC AMIDES AND THEIR COMPOSITIONS, METHODS OF USE AND PREPARATION DOW AGROSCIENCES LLC (US) 2001-03-01 — — WO disclosed
WO-2001005769-A2 FUNGICIDAL HETEROCYCLIC AROMATIC AMIDES AND THEIR COMPOSITIONS, METHODS OF USE AND PREPARATION DOW AGROSCIENCES LLC (US) 2001-01-25 — — WO disclosed
EP-0236913-A2 Aryl-azolylmethyl-benzocyclo-alkene derivatives, process for their preparation and their use HOECHST AKTIENGESELLSCHAFT (DE) 1987-09-16 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220380322-A1 P2X4 RECEPTOR ANTAGONIST P2RX7, P2RX1, P2RX2 TAAR1 310/4885NOTUM 3553/4885ALDH1A1 3019/4885
US-20240417379-A1 P2X4 RECEPTOR ANTAGONIST P2RX7, P2RX1, P2RX2 TAAR1 326/4885NOTUM 4236/4885ALDH1A1 3045/4885
US-12116351-B2 P2X4 receptor antagonist P2RX7, P2RX1, P2RX2 TAAR1 310/4885NOTUM 3553/4885ALDH1A1 3019/4885
US-20200223806-A1 P2X4 RECEPTOR ANTAGONIST P2RX7, P2RX1, P2RX2 TAAR1 310/4885NOTUM 3553/4885ALDH1A1 3019/4885
US-11434207-B2 P2X4 receptor antagonist P2RX7, P2RX1, P2RX2 TAAR1 310/4885NOTUM 3553/4885ALDH1A1 3019/4885
US-10633349-B2 P2X4 receptor antagonist P2RX7, P2RX1, P2RX2 TAAR1 310/4885NOTUM 3553/4885ALDH1A1 3019/4885
US-20010056179-A1 Selective linear peptides with melanocortin-4 receptor (MC4-R) agonist activity MC4R, MC3R, MC1R TAAR1 368/4885NOTUM 4582/4885ALDH1A1 4684/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback